Artificial Intelligence (AI) in Cancer Market Report

Global and Region Artificial Intelligence (AI) in Cancer Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 29, 2022
  • PAGES：189
  • REPORT CODE：GMM893608
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Artificial Varian Medical Systemsligence (AI) in Cancer market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Artificial Varian Medical Systemsligence (AI) in Cancermarket, defines the market attractiveness level of Artificial Varian Medical Systemsligence (AI) in Cancer market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Artificial Varian Medical Systemsligence (AI) in Cancer industry, describes the types of Artificial Varian Medical Systemsligence (AI) in Cancer market, the applications of major players and the market size, and deeply analyzes the current situation of the global Artificial Varian Medical Systemsligence (AI) in Cancer market and the development prospects and opportunities of Artificial Varian Medical Systemsligence (AI) in Cancer industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Artificial Varian Medical Systemsligence (AI) in Cancer market in Chapter 13.

    By Player:

    • Intel

    • IBM

    • MammoScreen

    • Varian Medical Systems

    • Volpara

    • Digital Reasoning

    • Densitas

    • Microsoft

    • Niramai

    • GE Healthcare

    • MVision AI

    • NVIDIA

    • Cancer Centerai

    • LungLifeAI

    • Johnson & Johnson

    By Type:

    • Surgery

    • Radiotherapy

    • Chemotherapy

    • Immunotherapy

    • Phototherapy

    • Gene Therapy

    • Sonodynamic Therapy

    By End-User:

    • Diagnosis

    • Therapy

    • Prognosis

    • Health Management

    • Research

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Artificial Varian Medical Systemsligence (AI) in Cancer Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Artificial Varian Medical Systemsligence (AI) in Cancer Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Artificial Varian Medical Systemsligence (AI) in Cancer Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Artificial Varian Medical Systemsligence (AI) in Cancer Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Artificial Varian Medical Systemsligence (AI) in Cancer Market Analysis and Outlook to 2022

    • 7.1 Global Artificial Varian Medical Systemsligence (AI) in Cancer Consumption (2017-2022)

    • 7.2 United States Artificial Varian Medical Systemsligence (AI) in Cancer Consumption (2017-2022)

    • 7.3 Europe Artificial Varian Medical Systemsligence (AI) in Cancer Consumption (2017-2022)

    • 7.4 China Artificial Varian Medical Systemsligence (AI) in Cancer Consumption (2017-2022)

    • 7.5 Japan Artificial Varian Medical Systemsligence (AI) in Cancer Consumption (2017-2022)

    • 7.6 India Artificial Varian Medical Systemsligence (AI) in Cancer Consumption (2017-2022)

    • 7.7 South Korea Artificial Varian Medical Systemsligence (AI) in Cancer Consumption (2017-2022)

    8 Region and Country-wise Artificial Varian Medical Systemsligence (AI) in Cancer Market Analysis and Outlook to 2028

    • 8.1 Global Artificial Varian Medical Systemsligence (AI) in Cancer Consumption Forecast (2022-2028)

    • 8.2 United States Artificial Varian Medical Systemsligence (AI) in Cancer Consumption Forecast (2022-2028)

    • 8.3 Europe Artificial Varian Medical Systemsligence (AI) in Cancer Consumption Forecast (2022-2028)

    • 8.4 China Artificial Varian Medical Systemsligence (AI) in Cancer Consumption Forecast (2022-2028)

    • 8.5 Japan Artificial Varian Medical Systemsligence (AI) in Cancer Consumption Forecast (2022-2028)

    • 8.6 India Artificial Varian Medical Systemsligence (AI) in Cancer Consumption Forecast (2022-2028)

    • 8.7 South Korea Artificial Varian Medical Systemsligence (AI) in Cancer Consumption Forecast (2022-2028)

    9 Global Artificial Varian Medical Systemsligence (AI) in Cancer Market Outlook by Types and Applications to 2022

    • 9.1 Global Artificial Varian Medical Systemsligence (AI) in Cancer Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Surgery Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Radiotherapy Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Chemotherapy Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Immunotherapy Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Phototherapy Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Gene Therapy Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Sonodynamic Therapy Consumption and Growth Rate (2017-2022)

    • 9.2 Global Artificial Varian Medical Systemsligence (AI) in Cancer Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Diagnosis Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Therapy Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Prognosis Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Health Management Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Research Consumption and Growth Rate (2017-2022)

    10 Global Artificial Varian Medical Systemsligence (AI) in Cancer Market Outlook by Types and Applications to 2028

    • 10.1 Global Artificial Varian Medical Systemsligence (AI) in Cancer Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Surgery Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Radiotherapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Phototherapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Gene Therapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.7 Global Sonodynamic Therapy Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Artificial Varian Medical Systemsligence (AI) in Cancer Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Diagnosis Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Therapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Prognosis Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Health Management Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Research Consumption Forecast and Growth Rate (2022-2028)

    11 Global Artificial Varian Medical Systemsligence (AI) in Cancer Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Artificial Varian Medical Systemsligence (AI) in Cancer Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Artificial Varian Medical Systemsligence (AI) in Cancer Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Artificial Varian Medical Systemsligence (AI) in Cancer Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Artificial Varian Medical Systemsligence (AI) in Cancer Market Competitive Analysis

    • 14.1 Intel

      • 14.1.1 Intel Company Details

      • 14.1.2 Intel Artificial Varian Medical Systemsligence (AI) in Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Intel Artificial Varian Medical Systemsligence (AI) in Cancer Product and Service

    • 14.2 IBM

      • 14.2.1 IBM Company Details

      • 14.2.2 IBM Artificial Varian Medical Systemsligence (AI) in Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 IBM Artificial Varian Medical Systemsligence (AI) in Cancer Product and Service

    • 14.3 MammoScreen

      • 14.3.1 MammoScreen Company Details

      • 14.3.2 MammoScreen Artificial Varian Medical Systemsligence (AI) in Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 MammoScreen Artificial Varian Medical Systemsligence (AI) in Cancer Product and Service

    • 14.4 Varian Medical Systems

      • 14.4.1 Varian Medical Systems Company Details

      • 14.4.2 Varian Medical Systems Artificial Varian Medical Systemsligence (AI) in Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Varian Medical Systems Artificial Varian Medical Systemsligence (AI) in Cancer Product and Service

    • 14.5 Volpara

      • 14.5.1 Volpara Company Details

      • 14.5.2 Volpara Artificial Varian Medical Systemsligence (AI) in Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Volpara Artificial Varian Medical Systemsligence (AI) in Cancer Product and Service

    • 14.6 Digital Reasoning

      • 14.6.1 Digital Reasoning Company Details

      • 14.6.2 Digital Reasoning Artificial Varian Medical Systemsligence (AI) in Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Digital Reasoning Artificial Varian Medical Systemsligence (AI) in Cancer Product and Service

    • 14.7 Densitas

      • 14.7.1 Densitas Company Details

      • 14.7.2 Densitas Artificial Varian Medical Systemsligence (AI) in Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Densitas Artificial Varian Medical Systemsligence (AI) in Cancer Product and Service

    • 14.8 Microsoft

      • 14.8.1 Microsoft Company Details

      • 14.8.2 Microsoft Artificial Varian Medical Systemsligence (AI) in Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Microsoft Artificial Varian Medical Systemsligence (AI) in Cancer Product and Service

    • 14.9 Niramai

      • 14.9.1 Niramai Company Details

      • 14.9.2 Niramai Artificial Varian Medical Systemsligence (AI) in Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Niramai Artificial Varian Medical Systemsligence (AI) in Cancer Product and Service

    • 14.10 GE Healthcare

      • 14.10.1 GE Healthcare Company Details

      • 14.10.2 GE Healthcare Artificial Varian Medical Systemsligence (AI) in Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 GE Healthcare Artificial Varian Medical Systemsligence (AI) in Cancer Product and Service

    • 14.11 MVision AI

      • 14.11.1 MVision AI Company Details

      • 14.11.2 MVision AI Artificial Varian Medical Systemsligence (AI) in Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 MVision AI Artificial Varian Medical Systemsligence (AI) in Cancer Product and Service

    • 14.12 NVIDIA

      • 14.12.1 NVIDIA Company Details

      • 14.12.2 NVIDIA Artificial Varian Medical Systemsligence (AI) in Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 NVIDIA Artificial Varian Medical Systemsligence (AI) in Cancer Product and Service

    • 14.13 Cancer Centerai

      • 14.13.1 Cancer Centerai Company Details

      • 14.13.2 Cancer Centerai Artificial Varian Medical Systemsligence (AI) in Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Cancer Centerai Artificial Varian Medical Systemsligence (AI) in Cancer Product and Service

    • 14.14 LungLifeAI

      • 14.14.1 LungLifeAI Company Details

      • 14.14.2 LungLifeAI Artificial Varian Medical Systemsligence (AI) in Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 LungLifeAI Artificial Varian Medical Systemsligence (AI) in Cancer Product and Service

    • 14.15 Johnson & Johnson

      • 14.15.1 Johnson & Johnson Company Details

      • 14.15.2 Johnson & Johnson Artificial Varian Medical Systemsligence (AI) in Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Johnson & Johnson Artificial Varian Medical Systemsligence (AI) in Cancer Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Artificial Varian Medical Systemsligence (AI) in Cancer

    • Figure Artificial Varian Medical Systemsligence (AI) in Cancer Picture

    • Table Global Artificial Varian Medical Systemsligence (AI) in Cancer Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Artificial Varian Medical Systemsligence (AI) in Cancer Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Artificial Varian Medical Systemsligence (AI) in Cancer Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Artificial Varian Medical Systemsligence (AI) in Cancer Consumption by Country (2017-2022)

    • Figure United States Artificial Varian Medical Systemsligence (AI) in Cancer Consumption and Growth Rate (2017-2022)

    • Table Europe Artificial Varian Medical Systemsligence (AI) in Cancer Consumption and Growth Rate (2017-2022)

    • Figure China Artificial Varian Medical Systemsligence (AI) in Cancer Consumption and Growth Rate (2017-2022)

    • Figure Japan Artificial Varian Medical Systemsligence (AI) in Cancer Consumption and Growth Rate (2017-2022)

    • Figure India Artificial Varian Medical Systemsligence (AI) in Cancer Consumption and Growth Rate (2017-2022)

    • Figure South Korea Artificial Varian Medical Systemsligence (AI) in Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Artificial Varian Medical Systemsligence (AI) in Cancer Consumption Forecast by Country (2022-2028)

    • Figure United States Artificial Varian Medical Systemsligence (AI) in Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Artificial Varian Medical Systemsligence (AI) in Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Artificial Varian Medical Systemsligence (AI) in Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Artificial Varian Medical Systemsligence (AI) in Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Artificial Varian Medical Systemsligence (AI) in Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Artificial Varian Medical Systemsligence (AI) in Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Surgery Consumption and Growth Rate (2017-2022)

    • Figure Global Radiotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Chemotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Phototherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Gene Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Sonodynamic Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Diagnosis Consumption and Growth Rate (2017-2022)

    • Figure Global Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Prognosis Consumption and Growth Rate (2017-2022)

    • Figure Global Health Management Consumption and Growth Rate (2017-2022)

    • Figure Global Research Consumption and Growth Rate (2017-2022)

    • Figure Global Surgery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Radiotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Phototherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Gene Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Sonodynamic Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diagnosis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Prognosis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Health Management Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Research Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Artificial Varian Medical Systemsligence (AI) in Cancer Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Artificial Varian Medical Systemsligence (AI) in Cancer Export by Region (Top 5 Countries) (2017-2028)

    • Table Intel (Foundation Year, Company Profile and etc.)

    • Table Intel Artificial Varian Medical Systemsligence (AI) in Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Intel Artificial Varian Medical Systemsligence (AI) in Cancer Product and Service

    • Table IBM (Foundation Year, Company Profile and etc.)

    • Table IBM Artificial Varian Medical Systemsligence (AI) in Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table IBM Artificial Varian Medical Systemsligence (AI) in Cancer Product and Service

    • Table MammoScreen (Foundation Year, Company Profile and etc.)

    • Table MammoScreen Artificial Varian Medical Systemsligence (AI) in Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table MammoScreen Artificial Varian Medical Systemsligence (AI) in Cancer Product and Service

    • Table Varian Medical Systems (Foundation Year, Company Profile and etc.)

    • Table Varian Medical Systems Artificial Varian Medical Systemsligence (AI) in Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Varian Medical Systems Artificial Varian Medical Systemsligence (AI) in Cancer Product and Service

    • Table Volpara (Foundation Year, Company Profile and etc.)

    • Table Volpara Artificial Varian Medical Systemsligence (AI) in Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Volpara Artificial Varian Medical Systemsligence (AI) in Cancer Product and Service

    • Table Digital Reasoning (Foundation Year, Company Profile and etc.)

    • Table Digital Reasoning Artificial Varian Medical Systemsligence (AI) in Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Digital Reasoning Artificial Varian Medical Systemsligence (AI) in Cancer Product and Service

    • Table Densitas (Foundation Year, Company Profile and etc.)

    • Table Densitas Artificial Varian Medical Systemsligence (AI) in Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Densitas Artificial Varian Medical Systemsligence (AI) in Cancer Product and Service

    • Table Microsoft (Foundation Year, Company Profile and etc.)

    • Table Microsoft Artificial Varian Medical Systemsligence (AI) in Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Microsoft Artificial Varian Medical Systemsligence (AI) in Cancer Product and Service

    • Table Niramai (Foundation Year, Company Profile and etc.)

    • Table Niramai Artificial Varian Medical Systemsligence (AI) in Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Niramai Artificial Varian Medical Systemsligence (AI) in Cancer Product and Service

    • Table GE Healthcare (Foundation Year, Company Profile and etc.)

    • Table GE Healthcare Artificial Varian Medical Systemsligence (AI) in Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table GE Healthcare Artificial Varian Medical Systemsligence (AI) in Cancer Product and Service

    • Table MVision AI (Foundation Year, Company Profile and etc.)

    • Table MVision AI Artificial Varian Medical Systemsligence (AI) in Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table MVision AI Artificial Varian Medical Systemsligence (AI) in Cancer Product and Service

    • Table NVIDIA (Foundation Year, Company Profile and etc.)

    • Table NVIDIA Artificial Varian Medical Systemsligence (AI) in Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table NVIDIA Artificial Varian Medical Systemsligence (AI) in Cancer Product and Service

    • Table Cancer Centerai (Foundation Year, Company Profile and etc.)

    • Table Cancer Centerai Artificial Varian Medical Systemsligence (AI) in Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cancer Centerai Artificial Varian Medical Systemsligence (AI) in Cancer Product and Service

    • Table LungLifeAI (Foundation Year, Company Profile and etc.)

    • Table LungLifeAI Artificial Varian Medical Systemsligence (AI) in Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table LungLifeAI Artificial Varian Medical Systemsligence (AI) in Cancer Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Artificial Varian Medical Systemsligence (AI) in Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Artificial Varian Medical Systemsligence (AI) in Cancer Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US